Esculentin-1a(1-21)NH2: A frog skin-derived peptide for microbial keratitis

Cellular and Molecular Life Sciences

Volumn 72, Issue 3, 2015, Pages 617-627

  Kolar, Satya Sree N ^a   Luca, Vincenzo ^b   Baidouri, Hasna ^a   Mannino, Giuseppe ^c   McDermott, Alison M ^a   Mangoni, Maria Luisa ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amphibian skin antimicrobial peptides; Antibiotic resistance; Innate immunity; Ocular surface infections

Indexed keywords

AMPHIBIAN PROTEIN; ANTIMICROBIAL CATIONIC PEPTIDE; ESCULENTIN PROTEIN, RANA ESCULENTA; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ADVERSE EFFECTS; ANALYSIS OF VARIANCE; ANIMAL; ANURA; CHEMISTRY; CONTACT LENS; CORNEA; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; ISOLATION AND PURIFICATION; KERATITIS; METABOLISM; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; SKIN;

AMPHIBIAN PROTEINS; ANALYSIS OF VARIANCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANURA; CONTACT LENSES; CORNEA; EPITHELIAL CELLS; HUMANS; KERATITIS; PSEUDOMONAS AERUGINOSA; SKIN; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84936131573     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1694-0     Document Type: Article

References (69)

1. Evans DJ, Fleiszig SM (2013) Why does the healthy cornea resist Pseudomonas aeruginosa infection? Am J Ophthalmol 155:961-970
2. Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, Stapleton F (2006) Microbial keratitis predisposing factors and morbidity. Ophthalmology 113:109-116
3. Thomas PA, Geraldine P (2007) Infectious keratitis. Curr Opin Infect Dis 20:129-141
4. Al-Mujaini A, Al-Kharusi N, Thakral A, Wali UK (2009) Bacterial keratitis: perspective on epidemiology, clinico-pathogenesis, diagnosis and treatment. Sultan Qaboos Univ Med J 9:184-195
5. Green M, Apel A, Stapleton F (2008) Risk factors and causative organisms in microbial keratitis. Cornea 27:22-27
6. Mela EK, Giannelou IP, Koliopoulos JX, Gartaganis SP (2003) Ulcerative keratitis in contact lens wearers. Eye Contact Lens 29:207-209
7. Schein OD, McNally JJ, Katz J, Chalmers RL, Tielsch JM, Alfonso E, Bullimore M, O'Day D, Shovlin J (2005) The incidence of microbial keratitis among wearers of a 30-day silicone hydrogel extended-wear contact lens. Ophthalmology 112:2172-2179
8. Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PO, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3:55-65
9. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilm: a common cause of persistent infections. Science 284:1318-1322
10. Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34-40
11. McDermott AM (2013) Antimicrobial compounds in tears. Exp Eye Res 117:53-61
12. Robertson DM (2013) The effects of silicone hydrogel lens wear on the corneal epithelium and risk for microbial keratitis. Eye Contact Lens 39:67-72
13. Evans DJ, Fleiszig SM (2013) Microbial keratitis: could contact lens material affect disease pathogenesis? Eye Contact Lens 39:73-78
14. Kung VL, Ozer EA, Hauser AR (2010) The accessory genome of Pseudomonas aeruginosa. Microbiol Mol Biol Rev 74:621-641
15. Willcox MD (2011) Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom 94:161-168
16. Szczotka-Flynn LB, Imamura Y, Chandra J, Yu C, Mukherjee PK, Pearlman E, Ghannoum MA (2009) Increased resistance of contact lens-related bacterial biofilms to antimicrobial activity of soft contact lens care solutions. Cornea 28:918-926
17. Maviglia R, Nestorini R, Pennisi M (2009) Role of old antibiotics in multidrug resistant bacterial infections. Curr Drug Targets 10:895-905
18. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA (2003) A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310
19. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551-1557
20. Shai Y (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248
21. Fjell CD, Hiss JA, Hancock RE, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11:37-51
22. Guani-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Teran LM (2010) Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 135:1-11
23. Dempsey CE, Hawrani A, Howe RA, Walsh TR (2010) Amphipathic antimicrobial peptides - from biophysics to therapeutics? Protein Pept Lett 17:1334-1344
24. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-720
25. Lai Y, Gallo RL (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30:131-141
26. Haney EF, Hancock RB (2013) Peptide design for antimicrobial and immunomodulatory applications. Biopolymers 100:572-583
27. Radek K, Gallo R (2007) Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol 29:27-43
28. Brown KL, Hancock RE (2006) Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 18:24-30
29. Mangoni ML, Miele R, Renda TG, Barra D, Simmaco M (2001) The synthesis of antimicrobial peptides in the skin of Rana esculenta is stimulated by microorganisms. FASEB J 15:1431-1432
30. Mangoni ML (2006) Temporins, anti-infective peptides with expanding properties. Cell Mol Life Sci 63:1060-1069
31. Conlon JM, Iwamuro S, King JD (2009) Dermal cytolytic peptides and the system of innate immunity in anurans. Ann N Y Acad Sci 1163:75-82
32. Simmaco M, Mignogna G, Barra D, Bossa F (1994) Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. J Biol Chem 269:11956-11961
33. Islas-Rodriguez AE, Marcellini L, Orioni B, Barra D, Stella L, Mangoni ML (2009) Esculentin 1-21: a linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria. J Pept Sci 15:607-614
34. Luca V, Stringaro A, Colone M, Pini A, Mangoni ML (2013) Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. Cell Mol Life Sci 70:2773-2786
35. Hancock RE, Rozek A (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 206:143-149
36. Mangoni ML, Shai Y (2011) Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action. Cell Mol Life Sci 68:2267-2280
37. Levy SB (2002) The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother 49:25-30
38. Huang LC, Redfern RL, Narayanan S, Reins RY, McDermott AM (2007) In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid. Antimicrob Agents Chemother 51:3853-3860
39. Robertson DM, Li L, Fisher S, Pearce VP, Shay JW, Wright WE, Cavanagh HD, Jester JV (2005) Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci 46:470-478
40. O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM (1996) Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci 37:534-543
41. Hobden JA, Masinick SA, Barrett RP, Hazlett LD (1995) Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci 36:1107-1114
42. Hazlett LD, Moon MM, Strejc M, Berk RS (1987) Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci 28:1978-1985
43. Cole N, Hume E, Khan S, Krockenberger M, Thakur A, Husband AJ, Willcox MD (2005) Interleukin-4 is not critical to pathogenesis in a mouse model of Pseudomonas aeruginosa corneal infection. Curr Eye Res 30:535-542
44. Singh S, Satani D, Patel A, Vhankade R (2012) Colored cosmetic contact lenses: an unsafe trend in the younger generation. Cornea 31:777-779
45. Knauf HP, Silvany R, Southern PM Jr, Risser RC, Wilson SE (1996) Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea 15:66-71
46. Estrellas PS Jr, Alionte LG, Hobden JA (2000) A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient. Curr Eye Res 20:157-165
47. Pinna A, Usai D, Sechi LA, Molicotti P, Zanetti S, Carta A (2008) Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers. Cornea 27:320-326
48. Ormerod LD, Smith RE (1986) Contact lens-associated microbial keratitis. Arch Ophthalmol 104:79-83
49. Mannis MJ (2002) The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis. Trans Am Ophthalmol Soc 100:243-271
50. Twining SS, Kirschner SE, Mahnke LA, Frank DW (1993) Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci 34:2699-2712
51. Chin GJ, Marx J (1994) Resistance to antibiotics. Science 264:359
52. Garg P, Sharma S, Rao GN (1999) Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 106:1319-1323
53. Cullor JS, Mannis MJ, Murphy CJ, Smith WL, Selsted ME, Reid TW (1990) In vitro antimicrobial activity of defensins against ocular pathogens. Arch Ophthalmol 108:861-864
54. Huang LC, Jean D, Proske RJ, Reins RY, McDermott AM (2007) Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res 32:595-609
55. Huang FD, Woodruff E, Mohrmann R, Broadie K (2006) Rolling blackout is required for synaptic vesicle exocytosis. J Neurosci 26:2369-2379
56. Schwab IR, Dries D, Cullor J, Smith W, Mannis M, Reid T, Murphy CJ (1992) Corneal storage medium preservation with defensins. Cornea 11:370-375
57. Sousa LB, Mannis MJ, Schwab IR, Cullor J, Hosotani H, Smith W, Jaynes J (1996) The use of synthetic Cecropin (D5C) in disinfecting contact lens solutions. CLAO J 22:114-117
58. Nos-Barbera S, Portoles M, Morilla A, Ubach J, Andreu D, Paterson CA (1997) Effect of hybrid peptides of cecropin A and melittin in an experimental model of bacterial keratitis. Cornea 16:101-106
59. McDermott AM, Rich D, Cullor J, Mannis MJ, Smith W, Reid T, Murphy CJ (2006) The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears. Br J Ophthalmol 90:609-611
60. McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ (2003) Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci 44:1859-1865
61. McDermott AM, Redfern RL, Zhang B (2001) Human beta-defensin 2 is up-regulated during re-epithelialization of the cornea. Curr Eye Res 22:64-67
62. Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM (1998) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102:874-880
63. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560
64. Santos CM, Kumar A, Kolar SS, Contreras-Caceres R, McDermott A, Cai C (2013) Immobilization of antimicrobial peptide IG-25 onto fluoropolymers via fluorous interactions and click chemistry. ACS Appl Mater Interfaces 5:12789-12793
65. Kumar A, Kolar SS, Zao M, McDermott AM, Cai C (2011) Localization of antimicrobial peptides on polymerized liposomes leading to their enhanced efficacy against Pseudomonas aeruginosa. Mol Bio Syst 7:711-713
66. Willcox MD, Hume EB, Aliwarga Y, Kumar N, Cole N (2008) A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. J Appl Microbiol 105:1817-1825
67. Dutta D, Cole N, Kumar N, Willcox MD (2013) Broad spectrum antimicrobial activity of melimine covalently bound to contact lenses. Invest Ophthalmol Vis Sci 54:175-182
68. Cole N, Hume EB, Vijay AK, Sankaridurg P, Kumar N, Willcox MD (2010) In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU. Invest Ophthalmol Vis Sci 51:390-395
69. Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, Pal T (2004) A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Regul Pept 118:135-141